Live June 28 @ 4:35 PM | Basel, Switzerland
CEO Dudley Tabakin and Chief Science Officer Kate Lynden will join a panel of experts from Roche to close out the conference with a discussion about the future of clinical innovation.
VivoSense Reps: Kate Lyden, Chief Science Officer and Patrick Hankey, VP of Business Development
The 2022 ACSM Annual Meeting, World Congress on Exercise is Medicine and World Congress on the Basic Science of Exercise and Vascular Health showcases the latest in exercise science and sports medicine.
VivoSense Rep: Rob Wilson, VP of Marketing Strategy
Hear from 30+ decentralized clinical trials innovators, including leading perspectives from pharma, biotech, patient group, CROs and service providers.
VivoSense Rep: Patrick Hankey, VP of Business Development
Explore ‘LIMITLESS’ possibilities alongside thousands of global biotechnology and pharma leaders as we dive into topics such as business development, healthcare innovations, and the future of biotechnology.
Speaker Panel: Dudley Tabakin, CEO and Kate Lyden, Chief Science Officer
VivoSense Rep: Rob Wilson, VP of Marketing Strategy
The conference agenda focuses on how life sciences organizations are improving clinical trial design, recruitment, and retention, while collecting better data, saving on trial costs, and ultimately delivering a better patient experience.
Speaker: Kate Lyden, Chief Science Officer
VivoSense Reps: Dudley Tabakin, CEO and Rob Wilson, VP of Marketing Strategy
The conference focuses on ways for pharma clinical trials to take advantage of new opportunities to collect better data and improve the patient experience; as well as how these new digital health tools supplement existing biomarker strategies.
Speaker: Clinical Scientist Jen Blankenship
VivoSense Reps: Thomas Leonard, VP of Sales and Patrick Hankey, VP of Business Development
Uniting industry experts dedicated to implementing digital biomarkers in Neurodegenerative, Movement and Neuropsychiatric Disorders clinical trials, this forum shares cross-industry insight to transform clinical development with digital data.
